PetDx® is a molecular diagnostics company enabling veterinarians to detect cancer in dogs with a simple blood draw. As a multi-cancer early detection (MCED) test, OncoK9® employs cutting-edge genomic analysis that leverages next-generation sequencing (NGS) technology and proprietary bioinformatics algorithms, empowering veterinarians to provide superior care to canine patients.
